Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vesico-Ureteral Reflux | 12 | 2021 | 424 | 2.940 |
Why?
|
Urinary Tract Infections | 8 | 2021 | 781 | 2.330 |
Why?
|
Ureteral Obstruction | 8 | 2022 | 300 | 2.180 |
Why?
|
Glycomics | 3 | 2021 | 123 | 1.900 |
Why?
|
Tandem Mass Spectrometry | 8 | 2021 | 1120 | 1.480 |
Why?
|
Hydronephrosis | 4 | 2022 | 275 | 1.350 |
Why?
|
Urine | 5 | 2020 | 380 | 1.330 |
Why?
|
Polysaccharides | 7 | 2021 | 994 | 1.230 |
Why?
|
Proteomics | 10 | 2021 | 3268 | 1.210 |
Why?
|
Urinary Tract | 7 | 2019 | 295 | 1.200 |
Why?
|
Urologic Diseases | 5 | 2019 | 252 | 1.140 |
Why?
|
Nephrectomy | 5 | 2018 | 1001 | 1.120 |
Why?
|
Robotics | 7 | 2010 | 869 | 1.070 |
Why?
|
Kidney | 12 | 2022 | 6910 | 1.030 |
Why?
|
Glycoproteins | 5 | 2016 | 2318 | 0.970 |
Why?
|
Glycosylation | 6 | 2021 | 1138 | 0.920 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 67 | 0.920 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 59 | 0.910 |
Why?
|
Proteome | 3 | 2020 | 1776 | 0.890 |
Why?
|
Laparoscopy | 10 | 2018 | 1996 | 0.810 |
Why?
|
Kidney Pelvis | 4 | 2022 | 180 | 0.710 |
Why?
|
Cryptorchidism | 2 | 2021 | 123 | 0.680 |
Why?
|
Radionuclide Imaging | 3 | 2020 | 2037 | 0.680 |
Why?
|
Urologic Surgical Procedures | 5 | 2018 | 293 | 0.660 |
Why?
|
Chromatography, Liquid | 6 | 2020 | 964 | 0.590 |
Why?
|
Adrenalectomy | 1 | 2018 | 312 | 0.580 |
Why?
|
Urography | 4 | 2019 | 326 | 0.560 |
Why?
|
Cicatrix | 2 | 2020 | 694 | 0.530 |
Why?
|
Proteins | 4 | 2013 | 6166 | 0.530 |
Why?
|
Urothelium | 1 | 2017 | 289 | 0.530 |
Why?
|
Ureter | 4 | 2015 | 363 | 0.510 |
Why?
|
Wilms Tumor | 1 | 2016 | 339 | 0.510 |
Why?
|
Bladder Exstrophy | 2 | 2022 | 92 | 0.500 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2014 | 179 | 0.490 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2012 | 27 | 0.460 |
Why?
|
Lymph Node Excision | 2 | 2018 | 1200 | 0.460 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 514 | 0.450 |
Why?
|
Urogenital Abnormalities | 3 | 2019 | 250 | 0.420 |
Why?
|
Microwaves | 1 | 2012 | 179 | 0.410 |
Why?
|
Infant | 23 | 2021 | 34574 | 0.400 |
Why?
|
Urethral Stricture | 1 | 2010 | 58 | 0.400 |
Why?
|
Cystostomy | 2 | 2007 | 27 | 0.390 |
Why?
|
Urinary Bladder | 1 | 2016 | 1139 | 0.370 |
Why?
|
Child, Preschool | 22 | 2022 | 41221 | 0.350 |
Why?
|
Replantation | 1 | 2010 | 149 | 0.350 |
Why?
|
Ultrasonography | 7 | 2020 | 5948 | 0.330 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2020 | 79 | 0.330 |
Why?
|
Immunoglobulin G | 3 | 2014 | 4486 | 0.320 |
Why?
|
Ureteral Diseases | 1 | 2007 | 65 | 0.320 |
Why?
|
Cloaca | 1 | 2006 | 45 | 0.310 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2007 | 81 | 0.310 |
Why?
|
Child | 24 | 2022 | 74387 | 0.300 |
Why?
|
Kidney Transplantation | 4 | 2007 | 4141 | 0.300 |
Why?
|
Body Burden | 1 | 2006 | 166 | 0.290 |
Why?
|
Proteinuria | 1 | 2008 | 630 | 0.280 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 2046 | 0.270 |
Why?
|
Urethral Obstruction | 2 | 2019 | 53 | 0.260 |
Why?
|
Kidney Neoplasms | 2 | 2018 | 4046 | 0.260 |
Why?
|
Male | 43 | 2022 | 351380 | 0.260 |
Why?
|
Humans | 68 | 2022 | 717237 | 0.250 |
Why?
|
Propylene Glycols | 1 | 2003 | 96 | 0.250 |
Why?
|
Carbohydrate Sequence | 2 | 2014 | 417 | 0.240 |
Why?
|
Cattle | 3 | 2014 | 4000 | 0.240 |
Why?
|
Kidney Calculi | 1 | 2007 | 449 | 0.230 |
Why?
|
Retroperitoneal Space | 2 | 2018 | 161 | 0.230 |
Why?
|
Safety Management | 1 | 2008 | 784 | 0.230 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 769 | 0.230 |
Why?
|
Radiation Protection | 1 | 2006 | 456 | 0.230 |
Why?
|
Histocompatibility | 1 | 2003 | 362 | 0.220 |
Why?
|
Urethra | 2 | 2019 | 409 | 0.220 |
Why?
|
Blood Component Removal | 1 | 2002 | 117 | 0.220 |
Why?
|
Hernia, Umbilical | 1 | 2022 | 94 | 0.220 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2105 | 0.220 |
Why?
|
Uromodulin | 1 | 2021 | 49 | 0.210 |
Why?
|
Renal Artery | 1 | 2003 | 408 | 0.210 |
Why?
|
Feasibility Studies | 5 | 2020 | 4921 | 0.210 |
Why?
|
Female | 36 | 2022 | 377909 | 0.210 |
Why?
|
Fetal Diseases | 1 | 2006 | 900 | 0.200 |
Why?
|
Aneurysm, False | 1 | 2003 | 286 | 0.200 |
Why?
|
Creatinine | 3 | 2020 | 1907 | 0.200 |
Why?
|
Adolescent | 18 | 2022 | 85139 | 0.200 |
Why?
|
Mannose | 1 | 2020 | 124 | 0.200 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 69 | 0.190 |
Why?
|
Molecular Sequence Annotation | 2 | 2013 | 550 | 0.190 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2022 | 144 | 0.190 |
Why?
|
Fucose | 1 | 2020 | 117 | 0.190 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2022 | 481 | 0.190 |
Why?
|
Fever | 2 | 2021 | 1590 | 0.190 |
Why?
|
Abnormalities, Multiple | 2 | 2022 | 1387 | 0.180 |
Why?
|
Pelvic Pain | 2 | 2021 | 248 | 0.180 |
Why?
|
Recurrence | 3 | 2020 | 8282 | 0.180 |
Why?
|
Radiation Injuries | 1 | 2006 | 1226 | 0.180 |
Why?
|
Retrospective Studies | 17 | 2022 | 72614 | 0.170 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 511 | 0.160 |
Why?
|
Contrast Media | 3 | 2020 | 5278 | 0.160 |
Why?
|
Radiopharmaceuticals | 3 | 2020 | 2760 | 0.160 |
Why?
|
Wounds, Nonpenetrating | 1 | 2003 | 766 | 0.160 |
Why?
|
Reconstructive Surgical Procedures | 3 | 2022 | 2127 | 0.150 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 265 | 0.150 |
Why?
|
Receptors, Nicotinic | 1 | 2019 | 491 | 0.150 |
Why?
|
Receptor, EphA2 | 1 | 2016 | 44 | 0.150 |
Why?
|
Pedigree | 3 | 2019 | 4723 | 0.140 |
Why?
|
Image Enhancement | 2 | 2020 | 2979 | 0.140 |
Why?
|
Sports | 1 | 2021 | 651 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2003 | 5152 | 0.140 |
Why?
|
Cohort Studies | 6 | 2020 | 39887 | 0.140 |
Why?
|
Endodermal Sinus Tumor | 1 | 2015 | 53 | 0.140 |
Why?
|
Urination Disorders | 2 | 2009 | 246 | 0.130 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14903 | 0.130 |
Why?
|
Metabolome | 1 | 2021 | 871 | 0.130 |
Why?
|
Silicon Dioxide | 1 | 2016 | 257 | 0.130 |
Why?
|
Treatment Outcome | 13 | 2018 | 62348 | 0.130 |
Why?
|
Hematuria | 2 | 2007 | 235 | 0.130 |
Why?
|
Dogs | 6 | 2004 | 4046 | 0.130 |
Why?
|
Urinary Diversion | 2 | 2019 | 140 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2019 | 805 | 0.120 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 701 | 0.120 |
Why?
|
Spermatic Cord Torsion | 1 | 2013 | 75 | 0.120 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 18738 | 0.120 |
Why?
|
Carbohydrate Conformation | 1 | 2013 | 205 | 0.120 |
Why?
|
Adult | 14 | 2022 | 212451 | 0.120 |
Why?
|
Ribonucleases | 1 | 2013 | 277 | 0.120 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1780 | 0.120 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 472 | 0.120 |
Why?
|
Genes, Dominant | 1 | 2015 | 904 | 0.110 |
Why?
|
Subcellular Fractions | 1 | 2013 | 573 | 0.110 |
Why?
|
Animals | 19 | 2018 | 170890 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1666 | 0.110 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2012 | 156 | 0.110 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 2827 | 0.110 |
Why?
|
Athletic Injuries | 1 | 2021 | 1142 | 0.110 |
Why?
|
Muscle, Smooth | 1 | 2015 | 955 | 0.100 |
Why?
|
Young Adult | 8 | 2022 | 56247 | 0.100 |
Why?
|
Molecular Weight | 1 | 2013 | 2448 | 0.100 |
Why?
|
Methods | 1 | 2010 | 1174 | 0.100 |
Why?
|
Brain Concussion | 1 | 2021 | 1308 | 0.100 |
Why?
|
Catalysis | 1 | 2012 | 821 | 0.100 |
Why?
|
Syndrome | 3 | 2022 | 3201 | 0.100 |
Why?
|
Transplantation Chimera | 2 | 2003 | 623 | 0.100 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4208 | 0.100 |
Why?
|
Fluorocarbons | 1 | 2013 | 361 | 0.100 |
Why?
|
Mass Screening | 2 | 2020 | 5213 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1787 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2020 | 24742 | 0.090 |
Why?
|
Length of Stay | 3 | 2008 | 6280 | 0.090 |
Why?
|
Aging | 1 | 2008 | 8376 | 0.090 |
Why?
|
Biofeedback, Psychology | 1 | 2009 | 111 | 0.090 |
Why?
|
Chemical Precipitation | 1 | 2008 | 187 | 0.090 |
Why?
|
Ultrafiltration | 1 | 2008 | 54 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 34502 | 0.090 |
Why?
|
Blotting, Western | 1 | 2017 | 5438 | 0.090 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 296 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2018 | 15126 | 0.080 |
Why?
|
Urolithiasis | 1 | 2009 | 117 | 0.080 |
Why?
|
Freezing | 1 | 2008 | 297 | 0.080 |
Why?
|
Mutation | 3 | 2019 | 29491 | 0.080 |
Why?
|
Prospective Studies | 4 | 2022 | 51275 | 0.080 |
Why?
|
Prognosis | 5 | 2019 | 29226 | 0.080 |
Why?
|
Algorithms | 3 | 2013 | 13718 | 0.080 |
Why?
|
Albumins | 1 | 2010 | 567 | 0.080 |
Why?
|
Radiation Dosage | 3 | 2011 | 2043 | 0.080 |
Why?
|
Nomograms | 1 | 2009 | 234 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4438 | 0.080 |
Why?
|
Up-Regulation | 1 | 2017 | 4356 | 0.080 |
Why?
|
Urinalysis | 1 | 2009 | 363 | 0.080 |
Why?
|
Orchiectomy | 2 | 2021 | 455 | 0.080 |
Why?
|
Pilot Projects | 1 | 2020 | 8066 | 0.080 |
Why?
|
Age Factors | 2 | 2018 | 18798 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2018 | 3433 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3512 | 0.070 |
Why?
|
Infant, Newborn, Diseases | 1 | 2010 | 558 | 0.070 |
Why?
|
Urodynamics | 1 | 2006 | 360 | 0.070 |
Why?
|
Suture Techniques | 2 | 2008 | 798 | 0.070 |
Why?
|
Transplantation, Homologous | 5 | 2005 | 4846 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 3008 | 0.070 |
Why?
|
Boston | 1 | 2018 | 9407 | 0.070 |
Why?
|
Stents | 2 | 2007 | 3309 | 0.070 |
Why?
|
Case Management | 1 | 2006 | 283 | 0.070 |
Why?
|
Risk Assessment | 3 | 2018 | 23542 | 0.060 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2004 | 106 | 0.060 |
Why?
|
Fibronectins | 1 | 2008 | 725 | 0.060 |
Why?
|
Graft Survival | 3 | 2003 | 3765 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19538 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20434 | 0.060 |
Why?
|
Rats, Wistar | 1 | 2008 | 2022 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3807 | 0.060 |
Why?
|
Appendix | 1 | 2004 | 113 | 0.060 |
Why?
|
Dystrophin | 1 | 2004 | 285 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9665 | 0.060 |
Why?
|
Cadherins | 1 | 2008 | 917 | 0.060 |
Why?
|
Isoantigens | 1 | 2005 | 583 | 0.060 |
Why?
|
Operating Rooms | 1 | 2010 | 809 | 0.060 |
Why?
|
Orchiopexy | 1 | 2021 | 14 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2004 | 1018 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5268 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2003 | 812 | 0.050 |
Why?
|
Congenital Abnormalities | 1 | 2006 | 698 | 0.050 |
Why?
|
Sphingosine | 1 | 2003 | 318 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39302 | 0.050 |
Why?
|
Quality of Life | 1 | 2002 | 11760 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2003 | 511 | 0.050 |
Why?
|
Graft Rejection | 2 | 2005 | 4411 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 2043 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2003 | 702 | 0.050 |
Why?
|
Reoperation | 2 | 2007 | 4186 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 1540 | 0.050 |
Why?
|
Cyclosporine | 1 | 2003 | 826 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5160 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4030 | 0.050 |
Why?
|
Short Bowel Syndrome | 1 | 2002 | 304 | 0.050 |
Why?
|
Genomic Imprinting | 1 | 2002 | 351 | 0.050 |
Why?
|
MicroRNAs | 1 | 2016 | 3680 | 0.050 |
Why?
|
Middle Aged | 4 | 2020 | 215041 | 0.050 |
Why?
|
Mouth Mucosa | 1 | 2022 | 432 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2013 | 18352 | 0.050 |
Why?
|
Computer Simulation | 1 | 2013 | 6099 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 10651 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16989 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2249 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2019 | 193 | 0.040 |
Why?
|
Ultrasonography, Prenatal | 1 | 2006 | 1600 | 0.040 |
Why?
|
Software | 1 | 2013 | 4367 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2022 | 335 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3750 | 0.040 |
Why?
|
Transplantation Tolerance | 1 | 2003 | 614 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 189 | 0.040 |
Why?
|
Genes | 1 | 2002 | 1976 | 0.040 |
Why?
|
CpG Islands | 1 | 2002 | 1162 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2006 | 21805 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 1997 | 61 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22929 | 0.040 |
Why?
|
Tissue Donors | 2 | 2005 | 2159 | 0.040 |
Why?
|
Vagina | 1 | 2022 | 779 | 0.040 |
Why?
|
Motion | 1 | 2020 | 773 | 0.040 |
Why?
|
Acute Disease | 2 | 2005 | 7177 | 0.040 |
Why?
|
Lung Transplantation | 1 | 2005 | 1158 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17432 | 0.040 |
Why?
|
Rats | 2 | 2016 | 25091 | 0.040 |
Why?
|
Intestine, Small | 1 | 2002 | 1227 | 0.040 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1172 | 0.040 |
Why?
|
Sirolimus | 1 | 2003 | 1574 | 0.040 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 315 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2785 | 0.030 |
Why?
|
Physician's Role | 1 | 2002 | 977 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 41095 | 0.030 |
Why?
|
Bone Screws | 1 | 1997 | 497 | 0.030 |
Why?
|
Brachytherapy | 1 | 2002 | 1288 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1046 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9773 | 0.030 |
Why?
|
Whole-Body Irradiation | 2 | 2004 | 456 | 0.030 |
Why?
|
Prostatectomy | 1 | 2002 | 1806 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2369 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1471 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2681 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 945 | 0.030 |
Why?
|
Base Sequence | 3 | 2015 | 13317 | 0.030 |
Why?
|
Swine, Miniature | 2 | 2005 | 960 | 0.030 |
Why?
|
Sequence Analysis, Protein | 1 | 2013 | 261 | 0.030 |
Why?
|
Artifacts | 1 | 2020 | 1911 | 0.030 |
Why?
|
Swine | 3 | 2008 | 5821 | 0.030 |
Why?
|
Necrosis | 1 | 2015 | 1650 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2002 | 1464 | 0.030 |
Why?
|
Pediatrics | 1 | 2006 | 3556 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 990 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9047 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1997 | 971 | 0.020 |
Why?
|
Radioisotope Renography | 1 | 2010 | 65 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3083 | 0.020 |
Why?
|
Joint Instability | 1 | 1997 | 749 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1841 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3968 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10542 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16404 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1916 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2009 | 390 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 323 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2467 | 0.020 |
Why?
|
DNA Methylation | 1 | 2002 | 4102 | 0.020 |
Why?
|
Survival Rate | 1 | 2003 | 13261 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1997 | 1207 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2816 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1902 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 2008 | 174 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 985 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 5143 | 0.020 |
Why?
|
United States | 3 | 2021 | 67798 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3704 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15271 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2570 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20653 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3564 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2010 | 906 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 820 | 0.020 |
Why?
|
Electron Transport | 1 | 2006 | 210 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2006 | 379 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4329 | 0.020 |
Why?
|
Electrons | 1 | 2006 | 266 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 578 | 0.020 |
Why?
|
Leukocytes | 2 | 2004 | 2103 | 0.020 |
Why?
|
Aged | 1 | 2018 | 162856 | 0.020 |
Why?
|
Ileum | 1 | 2008 | 564 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1195 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 16017 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2006 | 202 | 0.020 |
Why?
|
Mice | 4 | 2018 | 81126 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2004 | 4825 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2005 | 516 | 0.020 |
Why?
|
Lectins | 1 | 2006 | 559 | 0.020 |
Why?
|
Leukapheresis | 1 | 2003 | 126 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4916 | 0.020 |
Why?
|
Biopsy | 1 | 2015 | 6753 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2010 | 1148 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13307 | 0.010 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2002 | 51 | 0.010 |
Why?
|
Histocompatibility Antigens | 1 | 2003 | 527 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2003 | 537 | 0.010 |
Why?
|
Isoantibodies | 1 | 2005 | 669 | 0.010 |
Why?
|
Chromosomes | 1 | 2004 | 616 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 27306 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3273 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5883 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11777 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2004 | 837 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2002 | 1126 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 14243 | 0.010 |
Why?
|
Immunization | 1 | 2005 | 1278 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11200 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 15258 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3421 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2931 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 13274 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 70864 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1426 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4483 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2002 | 1248 | 0.010 |
Why?
|
Species Specificity | 1 | 2002 | 2620 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4935 | 0.010 |
Why?
|
Ilium | 1 | 1997 | 158 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12483 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1650 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3496 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6805 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7847 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2002 | 2019 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6542 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7074 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1997 | 2081 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 11276 | 0.010 |
Why?
|
Heart | 1 | 2003 | 4332 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 23409 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10802 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4993 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10376 | 0.000 |
Why?
|
Lung | 1 | 2005 | 9781 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 12433 | 0.000 |
Why?
|
Transcription Factors | 1 | 2002 | 12073 | 0.000 |
Why?
|